Answers are grounded in this paper and cite their sources.
Letrozole/abemaciclib demonstrated encouraging and durable evidence of activity in recurrent ER positive endometrioid EC.
No takes yet. Share an insight, caveat, or question.
Konstantinopoulos et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: